Sickle Cell Care Expansion Act of 2023

The Sickle Cell Care Expansion Act of 2023 (HR 3100) authorizes federal funding to expand access to sickle cell disease care and research. It creates scholarship and loan repayment programs ($150 million annually) for medical students and physicians specializing in sickle cell disease, requiring them to work in treatment or research for one year per scholarship year. The bill also funds community-based education grants ($50 million annually) for organizations to improve health literacy and access to services, and transition-of-care programs ($70 million annually) to support patients moving from pediatric to adult care, including mental health services and specialist training. These provisions directly affect sickle cell patients, healthcare providers, and community organizations serving affected populations.